Karen Lingnau

Interferon-Regulatory Factor 4 Is Essential for the Developmental Program of T Helper 9 Cells

Valérie Staudt, Evita Bothur, Matthias Klein et al. · Immunity · 2010 · 540 citations · Full text

Life Sciences, Immunology, Molecular Biology +14

Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers

Jaap T. van Dissel, Sandra M. Arend, Corine Prins et al. · Vaccine · 2010 · 202 citations

Life Sciences, Immunology, Microbiology +13

IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses

Carola Schellack, Karin Prinz, Alena Egyed et al. · Vaccine · 2006 · 157 citations

Life Sciences, Immunology, Adaptive Immunity +11

Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: A randomized, placebo controlled trial for dose optimization in 128 healthy subjects

Christa Firbas, Bernd Jilma, Erich Tauber et al. · Vaccine · 2006 · 140 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31

Else Marie Agger, Ida Rosenkrands, Anja Weinreich Olsen et al. · Vaccine · 2006 · 125 citations

Veterinary Medicine, Immunology, Infectious Diseases +14